How to deal with patients with atrial fibrillation during an epidemic?

Thumbnail Image
EJTCM_2020_3_1_Tomaszuk-Kazberuk.pdf (331.29 KB)
Authors
Tomaszuk-Kazberuk, Anna
Date
2020-05-29
Journal Title
Journal ISSN
Volume Title
Publisher
Medical University of GdaƄsk
License
Creative Commons License
Creative Commons Attribution-ShareAlike 3.0 Poland License
Abstract
Patients with atrial fibrillation (AF) due to old age and comorbidities are at a higher risk of SARS-CoV-2 infection. These patients should protect themselves by limiting contact with other people to an absolute minimum and they should be educated about hygiene, including careful hand washing. In general, the principles of antiarrhythmic drug treatment of quarantined, infected and asymptomatic individuals remain unchanged. In the hospital setting it is important to remember about possible interactions between anticoagulants, antibiotics, antiarrhythmic, antiviral and antimalarial drugs. The current pandemic also led to limitations regarding the implantation and control of implantable devices to an absolute minimum.
Description
Keywords
atrial fibrillation    coronavirus    infection    SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus- 2    COVID-19    Coronavirus disease 2019    non-vitamin K oral anticoagulants (NOACs
Citation
Tomaszuk-Kazberuk A. How to deal with patients with atrial fibrillation during an epidemic?. Eur J Transl Clin Med. 2020;3(1):53-59. DOI: 10.31373/ejtcm/120487
URI
https://depot.ceon.pl/handle/123456789/20176
Belongs to collection
ArtykuƂy / Articles